In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
about
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsThe use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.Natural killer T cells contribute to the control of acute retroviral infection.Optimizing NKT cell ligands as vaccine adjuvantsEngaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective.
P2860
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
@en
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
@nl
type
label
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
@en
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
@nl
prefLabel
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
@en
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
@nl
P2860
P356
P1476
In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide
@en
P2093
C S Fernandez
S Jegaskanda
P2860
P304
P356
10.1111/CEI.12132
P577
2013-09-01T00:00:00Z